GlobalData’s Biotech Strategy 2012: Licensing, Collaboration, and M&A Trends report analyzes 20 strategic deals struck by leading and promising biotech companies. The terms and strategic drivers of these deals are analyzed based on acquisition costs, strategic fit, potential revenues, competitive advantage as well as other measures to illustrate the strategies different companies are currently using to gain market share, increase shareholder value and bring innovative and life-saving products to the booming global pharmaceuticals market. This report is an essential source of information and analysis on global strategic deals involving the top players in the global pharmaceuticals market.
- The report provides full details of 20 significant deals from Q3 2011 to Q3 2012 involving promising biotech companies including deal terms and payment structure.
- The report provides analysis of the key drivers, trends, and strategies behind deals undertaken by biotech companies across important geographic regions including the US, EU, Asia-Pacific, Brazil, Russia, India, China, and other emerging markets.
- The report covers the six major therapy areas of cardiovascular disease, central nervous system (CNS), diabetes and metabolic, immunology, oncology, and respiratory.
- The report contains expert insights on the corporate strategies of emerging biotech companies seeking competitive advantage in the pharmaceuticals marketplace.
About The Report
The Biotech Strategy 2012 - Licensing, Collaboration, and M&A Trends report is an essential source of information and analysis on global strategic deals involving the top players in the global pharmaceuticals market. Using detailed company data and financial analysis, GlobalData has highlighted certain deals in the pharmaceuticals market, forming a basis for in-depth analysis of the factors driving deal-making in the industry, currently and into the future. The report discusses the key factors shaping and driving the global pharmaceutical industry, and provides insight on the competitive landscape and emerging strategies that are expected to significantly alter the market position of industry leaders.